wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28554630-A9E2FCEA-462B-4BC2-9D96-8F6AC04BA8A4
Q28554630-A9E2FCEA-462B-4BC2-9D96-8F6AC04BA8A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28554630-A9E2FCEA-462B-4BC2-9D96-8F6AC04BA8A4
Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study
P2860
Q28554630-A9E2FCEA-462B-4BC2-9D96-8F6AC04BA8A4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28554630-A9E2FCEA-462B-4BC2-9D96-8F6AC04BA8A4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7da684ffe8590bb3499f3890ed0271a2df9a063a
P2860
Lipid levels and changes in body fat distribution in treatment-naive, HIV-1-Infected adults treated with rilpivirine or Efavirenz for 96 weeks in the ECHO and THRIVE trials.